Tokyo, Japan

Takako Mae

This inventor holds 2 USPTO granted patents. Top assignees: Nippon Kayaku Kabushiki Kaisha, Takara Shuzo Co., Inc.. Active years: 1992-2001.


% Patents Active = 100.0

Average Co-Inventor Count = 5.3

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1992-2001

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Takako Mae: Innovator in Medical Research

Introduction

Takako Mae is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of medical research, particularly in organ transplantation and immunology. With a total of 2 patents, her work has the potential to impact patient care and treatment outcomes.

Latest Patents

Takako Mae's latest patents include a method for examining chronic rejection reactions following organ transplantation. This innovative method allows for the early detection of chronic rejection by assaying nitrogen trioxide (NO,) and matrix metalloproteinase (MMP)-2 in body fluids. Additionally, she has developed novel spergualin-related compounds that possess immunopotentiating activity, which are expected to be useful as immunopotentiators in warm-blooded animals.

Career Highlights

Throughout her career, Takako Mae has worked with notable companies such as Nippon Kayaku and Takara Shuzo Co., Inc. Her experience in these organizations has allowed her to advance her research and contribute to the development of new medical technologies.

Collaborations

Takako has collaborated with esteemed colleagues, including Isamu Koyama and Tadaki Yasumura. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Takako Mae's contributions to medical research and her innovative patents highlight her role as a leading inventor in her field. Her work continues to pave the way for advancements in organ transplantation and immunology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…